First, a RAD51D deletion that most likely is a germline (Class 4) variant, since it has been observed repeatedly (>5×) in oncogenetic screening of breast ovarian cancer families. The gene discussed is RAD51D; the disease is Hereditary breast and ovarian cancer syndrome.